TickerFacts.

Anika Therapeutics, Inc. (ANIK): Shares Outstanding

Annual figures by period end, from SEC filings.

13.89M
As of 2025-12-31
13.38M
As of 2026-06-30
-1.7%
3-year compound annual growth
-0.6%
5-year compound annual growth
-0.8%
10-year compound annual growth
15.04M2010-12-31: 13.48M2011-12-31: 13.63M2012-12-31: 13.87M2013-12-31: 14.29M2014-12-31: 14.85M2015-12-31: 15.04M2016-12-31: 14.63M2017-12-31: 14.69M2018-12-31: 14.21M2019-12-31: 14.31M2020-12-31: 14.33M2021-12-31: 14.44M2022-12-31: 14.62M2023-12-31: 14.66M2024-12-31: 14.42M2025-12-31: 13.89M13.89M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3113.89M-3.7%2026-03-03, Balance as of period end
2024-12-3114.42M-1.7%2026-03-03, Balance as of period end
2023-12-3114.66M+0.2%2025-03-17, Balance as of period end
2022-12-3114.62M+1.3%2024-03-15, Balance as of period end
2021-12-3114.44M+0.8%2023-03-16, Balance as of period end
2020-12-3114.33M+0.1%2022-03-11, Balance as of period end
2019-12-3114.31M+0.7%2021-04-26, Balance as of period end
2018-12-3114.21M-3.3%2020-03-06, Balance as of period end
2017-12-3114.69M+0.4%2019-02-27, Balance as of period end
2016-12-3114.63M-2.7%2018-02-27, Balance as of period end
2015-12-3115.04M+1.2%2017-02-24, Balance as of period end
2014-12-3114.85M+3.9%2016-03-10, Balance as of period end
2013-12-3114.29M+3.1%2015-03-13, Balance as of period end
2012-12-3113.87M+1.7%2014-03-13, Balance as of period end
2011-12-3113.63M+1.1%2013-03-14, Balance as of period end
2010-12-3113.48Mn/a2012-03-13, Balance as of period end